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doi:10.1016/j.ejvs.2010.01.027Abstract Aim: Occlusion or severe stenosis of pedal and plantar arteries limits surgical
options for critical limb ischaemia (CLI). Below-the-ankle (BTA) angioplasty is potentially
useful as an adjunct to proximal angioplasty. In this study, the feasibility and outcome of this
procedure were explored, as they have not been evaluated previously.
Methods: Patients’ demographics, indications, procedures and outcomes were recorded.
Outcomes were determined by technical success, primary patency, limb salvage and
amputation-free survival (AFS) rates.
Results: Between 2004 and 2008, 42 cases of BTA angioplasty were performed for 39
patients. Forty cases (95.2%) had CLI. Technical success was achieved in 88% of cases.
At 6, 12 and 24 months, AFS was 70.7%, 60.9% and 57.1%, limb salvage was 84.9%,
81.9% and 81.9% and patient survival was 83.3%, 73.8% and 67.3, respectively. Seven major
amputations (16.6%) were performed, four of which had failed angioplasty. Two patients
required re-intervention. Univariate analysis showed insulin-dependent diabetics,
occlusive lesions, failure of angioplasty and state of the run off to be the predictors of
limb loss.
Conclusions: BTA angioplasty for pedal and plantar arterial occlusive disease is technically
feasible. It has good medium-term clinical outcome and limb salvage in a group of patients
with poor surgical options.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights
reserved.855029314; fax: þ44 1216278691.
tinternet.com (M.F. Abdelhamid).
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Below-the-ankle Angioplasty 763The treatment options for patients with peripheral arterial
disease (PAD) have increased. This is due to the technical
and technological advancements in endovascular tech-
niques, namely the introduction of extremely low-profile
and dedicated devices and the development of subintimal
angioplasty.1e3
Although angioplasty for infrapopliteal lesions has been
discussed in many previous studies,4e9 no study has
described the efficacy and outcome of below-the-ankle
(BTA) angioplasty. To the best of our knowledge, only
a handful of case reports have demonstrated the feasibility
of angioplasty of the foot arteries.1,10,11 One report has
even presented the experience of dorsalis pedis artery
stenting in two cases.12
The development seen in the technologies used for
angioplasty of the leg arteries and increasing expertise
allowed the feasibility of BTA angioplasty. These develop-
ments have mirrored those used for coronary
angioplasty.11,12
The aim of this study is to present the experience of BTA
angioplasty in a single UK centre. We present the technical
success, early- and medium-term outcomes, limb salvage
rate and amputation-free survival (AFS).
Patients and Methods
We obtained a list of all patients who underwent pedal
and/or plantar angioplasty at Selly Oak Hospital, University
Hospital Birmingham NHS Foundation Trust, from January
2004 to November 2008. Patients were identified from
a prospectively collected database (Dendrite Clinical
Systems Ltd.). This list included names of patients, date of
birth, hospital numbers, demographic data, co-morbidities,
presentation, indication, date and type of intervention,
degree of urgency, drugs administered during the proce-
dure and their doses, side, site and type of lesions, intra-
luminal or subintimal dissection, maximum balloon
dilatation, technical success, complications and post-
procedural drugs. The list was organised on an Excel
spreadsheet (Microsoft Office 2007).
A retrospective review of prospectively collected data
was performed using the patients’ medical records. We
recorded the presence of associated lesions and whether
angioplastied or not, the degree of run off, the need for
digital amputation or debridement, patency rate, clinical
improvement, length of follow-up, limb salvage rate and
survival.
Guidelines from the Joint Council of The Society for
Vascular Surgery and the North American Chapter of the
International Society for Cardiovascular Surgery were used
to assess procedural success and outcome.13
Angioplasty
It is our policy to perform angioplasty for the diseased
dorsalis pedis and plantar arteries, if the lesion is suitable,
to restore the continuity of blood flow to the foot. The
indications of BTA angioplasty are the presence of tight
stenosis (>70%) and/or a segmental occlusion where there
is at least some filling of the target vessel beyond the
occluded segment. We would not normally tackle a footwhere there is no filling of named vessels beyond the
occlusion. Percutaneous angioplasty was performed in all
cases at the radiology department under local anaesthetic.
This was done through an ipsilateral femoral approach
except if there were associated ipsilateral or contralateral
iliac lesions that required angioplasty at the same setting.
In these situations, a contralateral femoral approach was
used. Angioplasty was performed transluminally or sub-
intimally depending on the nature and the position of the
lesion. A 4-French vascular introducer was positioned to
perform a preliminary angiographic study using the non-
ionic iso-osmolar contrast medium Visipaque (iodixanol)
320 diluted up to 50%. A V-18 Control Wire 0.018-inch
hydrophilic guide wire (Boston Scientific Corporation,
Natick, MA, USA) was traversed through the arterial
obstruction sites and 2e3 mm diameter 3e3.5 French shaft
SAVVY 4e10 mm long balloon catheter (Cordis Corpora-
tion, Miami Lakes, FL, USA) was used to dilate the arteries.
Vessel re-canalisation was considered successful if direct
flow was restored in the treated vessel with no residual
stenosis >30% of the vessel diameter along the whole
artery. During the procedure, sodium heparin (2000e5000
IU) bolus was infused into the arterial lumen; if vessel
spasm occurred, a papaverine (15e30 mg) bolus was
injected intra-arterially. Patients were prescribed dual
anti-platelet therapy, aspirin 75 mg and clopidogrel 75 mg,
for a month to be followed by lifelong aspirin 75 mg once
per day unless contraindicated.
Follow-up
Patients who had digital amputation or wound debridement
before or after BTA, stayed in the hospital until they
showed signs of good healing. Patients who had BTA as day
cases were discharged on the same day. Following
discharge from the hospital, patients were seen in the
outpatient clinic within 6 weeks. Thereafter, patients were
followed-up according to their clinical condition. Patients
with foot ulcers or wounds were followed-up until complete
healing. Patients were discharged from the clinic if they
were asymptomatic for a year. Follow-up depended on
clinical evaluation of the vascularity of the foot. Detecting
the pulse, manually or by Doppler, or duplex scanning, in
addition to signs of wound healing, was the main method of
assessment. Ankle brachial pressure index (ABPI) was not
relied on as two-thirds of patients were diabetics. Toe
pressure and transcutaneous oxygen tension (TcPO2) were
not performed as these do not include in the regular follow-
up assessment in our centre. Patients who had major
amputation were discharged from the clinic after the
healing of their amputation stump.
Statistical Analysis
Major limb amputation was the primary endpoint. Univariate
testing for clinical variables was performed by using the chi
square test for proportions for nominal variables and
Cochran’s test for trend for ordinal variables. P < 0.05 was
considered significant. The time to major amputation and
death was studied by applying KaplaneMeier analysis to
produce survival curves and the log-rank test was performed
Table 2 Number of treated stenoses or occlusions in each
artery from January 2004 to November 2008.
Artery Number of lesions
angioplastied
Infra-renal Aorta 16
Iliac arteries 552
Superficial Femoral artery 1499
Profunda femoris artery 47
Popliteal artery 418
Tibio-peroneal trunk 141
Anterior Tibial artery 221
Posterior Tibial Artery 113
Peroneal artery 126
Graft angioplasty 90
Dorsalis Pedis artery 30
Plantar artery 14
764 M.F. Abdelhamid et al.to compare survival curves. The data were analysed with
SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
From January 2004 to November 2008, we performed
angioplasty for 3267 lesions in the radiology department at
Selly Oak hospital for 1349 patients. Out of these, 42 cases
of BTA angioplasty were performed for 39 patients. In two
cases, both dorsalis pedis and plantar arteries were treated
in the same foot. Table 1 shows the demographic data of
these patients. Table 2 shows the breakdown of the lesions
in different arteries.
Patients presented with critical limb ischaemia (CLI) in
95.2% of cases (40 legs). This was in the form of rest pain for
more than 2 weeks, ulceration or gangrene. Patients were
treated as urgent in patients in 71.4% of cases and the
remaining cases were treated as day cases. At time of
intervention, 29 patients (74.4%) were older than 65.
In all cases, except one, the lesions were tackled
through the ipsilateral approach. In this exceptional case,
there was a contralateral iliac lesion that was treated in the
same sitting. The dorsalis pedis and plantar arteries were
involved in 71.4% and 33.3% of cases, respectively.(Figs. 1
and 2) In 38.1% of cases, the involved arteries showed
occlusive lesions. In all 42 cases, there were associated
lesions in one or more of the tibial arteries. The state of
distal run off is shown in Table 3. The femoro-popliteal
segments had associated lesions in 42.9% of cases. Associ-
ated femoro-popliteal and tibial arterial lesions were
treated with the same procedure. Transluminal angioplasty
(TLA) was performed in 40 cases and subintimal angioplasty
(SIA) was performed in two cases. Rupture of the treated
artery occurred in one case, which did not require surgical
intervention. Angiographic success was achieved in 88% of
cases and five cases (12%) had failed angioplasty (Fig. 3).
Eleven patients (26.2%) had toe amputation in the same
admission. Major amputation in the form of below-knee
amputation (BKA) was performed in seven cases (16.6%).
Four were performed during the same admission and three
had BKA at 4 weeks, 4 and 6 months, respectively. Limb loss
was significantly greater in patients with occlusive than
stenotic lesions (p 0.001) and in those who had failed
in comparison with successful angioplasty (p < 0.001)
(Chi square test). Sex, diabetes mellitus, hypertension,
chronic renal failure, smoking and high blood cholesterol
were not significant risk factors for limb loss (Table 1). Mean
follow-up was 15.37 months (SE 2.6).Table 1 Demographic data of 39 patients.
Number (%) p-valuea
Males 26 (66.6) 0.205
Mean age 72.41 e
Diabetes Mellitus 26 (66.7) 0.058
Hypertension 27 (69.2) 0.884
Hypercholesterolemia 34 (87.2) 0.863
Smoking 31 (79.5) 0.41
Chronic Renal Failure 6 (15.3) 0.072
a p-value was measured by a Chi squared test to assess
significance for limb loss.At 6, 12 and 24 months, AFS was 70.7%, 60.9% and 57.1%,
respectively. Limb salvage rate was 84.9%, 81.9% and 81.9%
and patient survival rate was 83.3%, 73.8% and 67.3 at the
same periods, respectively (Figs. 4, 5 and 6).
Discussion
Revascularisation by means of percutaneous transluminal
angioplasty (PTA) has become the first line of management
for patients with PAD. In patients with CLI, the aim of
revascularisation is to provide sufficient blood flow to
relieve rest pain and/or allow healing of the ischaemic foot
lesion.14,15 The ideal revascularisation is the one that
avoids a general anaesthesia, poses a lesser systemic stress
and has fewer serious complications.2
PAD is more common in diabetics and presents at young
age with minimal sex difference. It is usually multilevel,
more distal and progresses faster to CLI.16 Diabetic patients
are significantly less able to develop arterial collaterals and
this explains why the majority of patients with CLI are
diabetics.17,18 The anatomical distribution of PAD is specific
in diabetics. In one study examining 417 CLI diabetic
patients with ischaemic foot lesions undergoing lower limb
angiography, 74% of lesions were in below-the-knee (BTK)
arteries. A total of 66% of these lesions were occlusive in
nature and all BTK arteries were occluded in 28%.19
Patients with CLI commonly present with lesions in BTA
arteries. Occlusion of dorsalis pedis and plantar arteries is
a serious cause of CLI. This anatomical pattern may prohibit
distal bypass for limb salvage or render it unsafe.11,13 We
believe, like others, that establishing the continuity of
blood flow to at least one foot artery is essential for healing
of ischaemic foot lesions.11,13 Therefore, we have been
performing BTA angioplasty at our centre since 2004 for all
patients with lesions in the dorsalis pedis and/or plantar
arteries that are suitable for angioplasty. During the period
of 5 years, we performed 42 foot angioplasties mainly for
CLI. In our protocol, PTA was the first-choice procedure for
revascularisation.
Improvements in the development of devices and the
operator’s skills have led to increased success rates for BTA
Figure 1 a: Foot angiography showing severe stenosis of DP artery, b: DP angioplasty using 2 mm balloon, c: completion
angiography.
Below-the-ankle Angioplasty 765angioplasty. The characteristics of instruments used for this
technique are extremely low-profile with the tip tapered to
a 3-French crossing profile and varying balloon lengths (120e
210 mm). It is worth noting that the use of over-the-wire
technique provided superior pushability characteristics.
Out of the 42 procedures, five failed. In two of these
cases, it was not possible to cross the lesion and, in one
case, it was not possible to traverse the arterial lumen
distal to the lesion. In the last two cases, there was
immediate re-occlusion after SIA. Four of these five
patients had BKA. Recurrence of symptoms occurred in twoFigure 2 a: multiple stenosis of the plantar artery, b: balloon an
angiography.cases and re-intervention in the form of repeat angioplasty
was performed at 6 and 9 months, respectively.
Fusaro et al.10 restored the continuity between plantar
and dorsalis pedis arteries using SIA in an 84-year-old lady
who presented with ischaemic foot ulcer. Fusaro also
described a pedaleplantar loop technique.1 He used this
technique as he could not cross the occluded dorsalis pedis
artery. He used a perforator branch to reach the plantar
artery and hence the posterior tibial artery. This technique
of using the collateral arteries has been used in coronary
intervention.20 Patients in both reports were diabetics. Onegioplasty of plantar artery using 2 mm balloon, c: completion
Table 3 State of run off.
Run off arteries Number of patients (%)
0 (no run off artery) 1 (2.4)
1 (one run off artery) 28 (66.7)
2 (two run off arteries) 10 (23.8)
3 (three run off arteries) 3 (7.1)
Figure 4 survival curve showing Amputation-Free Survival.
766 M.F. Abdelhamid et al.case showed complete healing of the ulcer at 4 months with
no outcome reported about the second case.
Kawarada and Yokoi12 attempted to establish ‘one
straight-line flow’ to the pedal arch by dorsalis pedis
angioplasty. However, there was immediate dissection of
the dorsalis pedis artery in one case and recurrent occlusion
of the other case after 13 days. Kawarada and Yokoi used
bare metal coronary stents to establish the antegrade flow
from the anterior tibial artery to the dorsalis pedis artery.
Dorsalis pedis pulse continued to be present up to 3 and
12 months, respectively. In the absence of randomised
clinical trials to judge this technique, we believe that
stenting of the dorsalis pedis artery should be a last option
because the incidence of in-stent restenosis in such small
arteries would be high and might compromise further
intervention.
In our series, complete resolution of rest pain was ach-
ieved following BTA angioplasty. Wound healing was
complete within 6 months after the procedure. Recurrence
of symptoms requiring BTA re-angioplasty occurred in two
cases. In one other case, recurrent symptoms required
repeated angioplasties of a femoro-popliteal bypass graft,
while the dorsalis pedis artery remained patent.
Our patients, like patients from other reports, under-
went BTA angioplasty in addition to proximal, mainly tibial,
angioplasty. This is because localised disease affecting the
foot arteries with no proximal lesions does not, or rarely,
exists. This could raise the question whether the results areFigure 3 a: complete occlusion of Plantar artery, b: lesion was
balloon, c: immediate re-occlusion.due to BTA angioplasty or proximal angioplasty. We believe
both proximal and distal angioplasties contribute to clinical
improvement because four of the five patients (80%) whose
BTA angioplasty failed required BKA.
Limitations
One of the limitations of this study is that patients were
discharged from the clinic after the disappearance of
symptoms. However, we overcame this by reviewing theirsuccessfully dissected subintimally and ballooned using 3 mm
Figure 5 survival curves showing limb salvage rate.
Below-the-ankle Angioplasty 767medical records to find any suggestion of the return of
symptoms. Patients were contacted to make sure they were
not referred to another hospital with recurrent symptoms.
Another limitation is the absence of an objective method,
such as toe pressure or TcPO2, to assess the outcome of theFigure 6 survival curves showing survival rates.procedure. This is because we do not use these tests in day-
to-day clinical practice. We rely on the clinical outcome
represented by improvement of symptoms, healing of tissue
loss, presence of pulses, good vascularity of the foot and
patency of the arteries in duplex scanning.
Conclusion
BTA angioplasty is feasible. It provides good medium-term
clinical outcome in a group of patients with limited treat-
ment options. It is used as an adjunct to proximal angio-
plasty to increase the limb salvage rate. A randomised
control trial is needed to establish the evidence-based
results of this technique.
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